Lack of influence of COMT Val158Met genotype on cognition in first-episode non-affective psychosis

Schizophrenia Research

Volumn 102, Issue 1-3, 2008, Pages 206-209

  Mata, Ignacio ^a   Perez Iglesias, Rocio ^a   Pelayo Teran, Jose Maria ^a   Rodríguez Sanchez, Jose Manuel ^a   Gonzalez Blanch, Cesar ^a   Carrasco Marin, Eugenio ^a   Vazquez Barquero, Jose Luis ^a   Crespo Facorro, Benedicto ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Cognition; COMT; First episode; Psychosis; Schizophrenia

Indexed keywords

CATECHOL METHYLTRANSFERASE; HALOPERIDOL; OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DNA POLYMORPHISM; DRUG EFFICACY; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE;

ADULT; ANTIPSYCHOTIC AGENTS; CATECHOL O-METHYLTRANSFERASE; COGNITION DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MALE; METHIONINE; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; VALINE;

EID: 46249101486     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2008.02.011     Document Type: Article

References (14)

1. Barnett J.H., Jones P.B., Robbins T.W., and Müller U. Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sorting Test in schizophrenia and healthy controls. Mol. Psychiatry 12 (2007) 502-509
2. Bertolino A., Casorio G., Blasi G., De Candia M., Latorre V., Petruzzella V., Altamura M., Nappi G., Papa S., Callicott J.H., Mattay V.S., Bellomo A., Scarabino T., Weinberger D.R., and Nardini M. Interaction of COMT Val108/158Met genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am. J. Psychiatry 161 (2004) 1798-1805
3. Bilder R.M., Volavka J., Czobor P., Malhotra A.K., Kennedy J.L., Ni X., et al. Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia. Biol. Psychiatry 52 (2002) 701-707
4. Crespo-Facorro B., Perez-Iglesias R., Ramirez-Bonilla M.L., Martinez-Garcia O., Llorca J., and Vazquez-Barquero J.L. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis. J. Clin. Psychiatry 67 (2006) 1511-1521
5. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., et al. Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. PNAS 98 (2001) 6917-6922
6. Fan J.B., Zhang C.S., Gu N.F., Li X.W., Sun W.W., Wang H.Y., et al. Catechol-O-methyltransferase gene Val/met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biol. Psychiatry 57 (2005) 139-144
7. Glatt S.J., Faraone S.V., and Tsuang M.T. Association between a functional Catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am. J. Psychiatry 160 (2003) 469-476
8. Goldberg T.E., Egan M.F., Gscheidle T., Coppola R., Weickert T., Kolachana B.S., et al. Executive subprocesses in working memory: relationship to Catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch. Gen. Psychiatry 60 (2003) 889-896
9. Han D.H., Kee B.S., Min K.J., Lee Y.S., Na C., Park D.B., and Lyoo I.K. Effects of catechol-O-mathyltransferase Val158Met polymorphism on the cognitive stability and aggression in the first-onset schizophrenic patients. Neuroreport 17 (2006) 95-99
10. Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Melen K., Julkunen I., and Taskinen J. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34 (1995) 4202-4210
11. Mata I., Arranz M.J., Staddon S., Lopez-Ilundain J.M., Tabares-Seisdedos R., and Murray R.M. The high-activity Val allele of the COMT gene predicts greater cognitive deterioration in patients with psychosis. Psychiatr. Genet. 16 (2006) 213-216
12. Munafo M.R., Bowes L., Clark T.G., and Flint J. Lack of association of the COMT (Val158/108Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol. Psychiatry 10 (2005) 765-770
13. Nolan K.A., Bilder R.M., Lachman H.M., and Volavka J. Catechol-O-methyltrasferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. Am. J. Psychiatry 161 (2004) 359-361
14. Woodward N.D., Jayathilake K., and Meltzer H.Y. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia. Schizophr. Res. 90 (2007) 86-96